Scleroderma News and Research

RSS
Scleroderma is a chronic, often progressive, autoimmune disease in which the body's immune system attacks its own body. The disease, which literally means "hard skin," can cause a thickening and tightening of the skin. In some cases it causes serious damage to internal organs including the lungs, heart, kidneys, esophagus and gastrointestinal tract. Some medicines and treatments can help with certain symptoms, but there is still no cure for scleroderma, which affects about 300,000 nationwide. (By way of comparison, about 50,000 people have muscular dystrophy, 250,000 are estimated to have lupus and 350,000 have multiple sclerosis.)
Gene therapy transforms life for men with severe form of hemophilia B

Gene therapy transforms life for men with severe form of hemophilia B

New potential therapeutic targets for treatment of pulmonary arterial hypertension

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Researchers working to develop new drugs for treating chronic inflammatory diseases

Researchers working to develop new drugs for treating chronic inflammatory diseases

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

Dentists’ awareness can improve oral health of scleroderma patients

Dentists’ awareness can improve oral health of scleroderma patients

PAH risk factors identified for systemic sclerosis patients

PAH risk factors identified for systemic sclerosis patients

Northwestern Medicine study provides new insights on tissue scarring in scleroderma

Northwestern Medicine study provides new insights on tissue scarring in scleroderma

Research provides new approach to developing better treatment options for scleroderma

Research provides new approach to developing better treatment options for scleroderma

Royal Free London NHS Foundation Trust selects OpenText to manage scanned legacy case-notes

Royal Free London NHS Foundation Trust selects OpenText to manage scanned legacy case-notes

Scientists find origin of Leri's pleonosteosis in children and adults

Scientists find origin of Leri's pleonosteosis in children and adults

Johns Hopkins researchers discover some cases of scleroderma likely to be initiated by cancer

Johns Hopkins researchers discover some cases of scleroderma likely to be initiated by cancer

Cancer triggers scleroderma, shows evidence

Cancer triggers scleroderma, shows evidence

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Women taking immunosuppressive medications during pregnancy do not put their babies at risk

Women taking immunosuppressive medications during pregnancy do not put their babies at risk

National autoimmune disease multi-city conference tour to arrive in Charleston, SC on November 2

National autoimmune disease multi-city conference tour to arrive in Charleston, SC on November 2

Research points to causes, potential treatment approaches for systemic sclerosis

Research points to causes, potential treatment approaches for systemic sclerosis

Key findings may have broad implications for future scleroderma therapy

Key findings may have broad implications for future scleroderma therapy

New classification criteria for systemic sclerosis published in ACR journal

New classification criteria for systemic sclerosis published in ACR journal

Researchers create specific tests to detect cancer biomarkers in patients with dermatomyositis

Researchers create specific tests to detect cancer biomarkers in patients with dermatomyositis

Pulmonary hypertension may be caused by molecular pathway that damages blood vessels

Pulmonary hypertension may be caused by molecular pathway that damages blood vessels